HSPB1 and lung cancer: The combination of HSP90 and HSP27 inhibitors to enhance the suppressive effect in breast cancer stem-like cells was proposed by Lee et al. [19] and decreased survival of lung cancer stem cells – otherwise resistant to chemotherapy – has been demonstrated by Hsu et al. using Quercetin to down-regulate HSP27 expression [20].